@article {1364625,
	title = {A brief history of anti-VEGF for the treatment of ocular angiogenesis},
	journal = {Am J Pathol},
	volume = {181},
	number = {2},
	year = {2012},
	month = {2012 Aug},
	pages = {376-9},
	abstract = {In 1994, The American Journal of Pathology published a key article reporting that hypoxic retina produces vascular endothelial growth factor (VEGF), suggesting a role for VEGF in ocular neovascularization. Subsequent developments in anti-VEGF treatment for neovascular eye disease have improved visual outcomes and changed the standard of care in retinal medicine and ophthalmology.},
	keywords = {Angiogenesis Inhibitors, Animals, Eye, History, 20th Century, History, 21st Century, Humans, Neovascularization, Pathologic, Vascular Endothelial Growth Factor A},
	issn = {1525-2191},
	doi = {10.1016/j.ajpath.2012.06.006},
	author = {Kim, Leo A and D{\textquoteright}Amore, Patricia A}
}
